Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant.
Saved in:
| Title: | Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant. |
|---|---|
| Authors: | Chang CC; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Liu YN; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Xu Z; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Vasilescu ER; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Li P; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Ho EK; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Li M; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Husain SA; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, United States.; Department of Epidemiology, The Columbia University Renal Epidemiology Group, Columbia University, New York, NY, United States., Bhagat G; Department of Pathology and Cell Biology, Division of Hematopathology, Columbia University Irving Medical Center, New York, NY, United States., Mohan S; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY, United States.; Department of Epidemiology, The Columbia University Renal Epidemiology Group, Columbia University, New York, NY, United States., Vlad G; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States., Suciu-Foca N; Department of Pathology and Cell Biology, Division of Immunogenetics and Cellular Immunology, Columbia University Irving Medical Center, New York, NY, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1664371. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
